Deepak Nitrite Ltd

- Total announced project capex is around INR 11,000 crore, covering multiple projects. - Funding will be in a 60:40 debt-equity ratio. - Bank loans for debt portion are already tied up. - Equity contribution has commenced; once 25% equity (of the 40%) is infused, debt drawdown will begin. - The company is generating sufficient internal cash flows to fund equity. - If additional funds are needed beyond planned bank loans, the company may approach capital markets. - Overall, funding is not expected to be an issue given cash generation and banking arrangements.

- Total announced project capex is around INR 11,000 crore, including multiple projects. - The Polycarbonate (PC) project is expected to be commissioned by June 2028. - Strategic investments are progressing as planned to support product diversification, import substitution, and margin improvement. - A dedicated on-site HyCO plant at the Dahej facility is being established via a long-term agreement with Praxair India under a Build-Own-Operate model to enhance execution visibility and reduce upfront investment. - Initiatives include expansions into downstream chemistries and integrated manufacturing capabilities. - New products including fluorinated molecules (INR 220 crore capex) have started production, targeting commercial scale by Q3 FY27. - MIBK/MIBC plants are nearing mechanical completion with commissioning expected by late Q1 or early Q2 FY27. - Funding is through a mix of 60% bank debt and 40% equity; debt tie-ups are in place with equity infusion underway.

- Advanced Intermediates segment expects healthy volume growth supported by stable domestic demand and improving pricing environment. (Page 5 and 11) - Phenolics segment anticipates better performance in Q1 FY27 over Q4 FY26 with high plant efficiencies and no feedstock constraints. (Page 12) - New products including fluorinated molecules and downstream chemistries to contribute to revenue from Q3 FY27 onwards. (Page 7 and 12) - Expansion projects like polycarbonate and agrochemical intermediates on track to support product diversification and margin improvement. (Pages 4, 6) - Market conditions to remain influenced by geopolitical factors and Chinese supply dynamics, but company expects margin improvement and volume growth in FY27. (Page 12) - Continued focus on portfolio optimization, deeper customer engagements, and cost efficiencies to drive long-term competitiveness and revenue growth. (Page 5 and 11)

- FY27 is expected to show a stronger margin profile and improving earnings trends compared to FY26, driven by new downstream products, especially in agri-chemicals and advanced intermediates. - Continuous product expansion, portfolio optimization, and cost efficiencies are anticipated to support growth and margin improvement. - Integrated manufacturing and backward integration are set to boost structural margin benefits and improve competitiveness. - New projects like the polycarbonate facility, MIBK and MIBC plants, and fluorinated molecules are on track to start commercial production in FY27, contributing to revenue and profit growth. - Management anticipates stable or improving profitability in Q1 FY27 compared to Q4 FY26, driven by improved spreads and downstream demand recovery. - Strategic initiatives and improved feedstock procurement reduce volatility risk, supporting sustainable margin expansion. - Dividend and capital allocation policy indicates commitment to long-term value creation alongside growth. - Overall, earnings, operating profits, and EPS are expected to grow in FY27 on the back of operational excellence and strategic expansions.

The provided transcript from the Deepak Nitrite Limited Q4 & FY26 Earnings Conference Call does not explicitly mention the current or expected order book or pending orders details. Key takeaways related to business outlook and operations include: - Strong demand with stable or improving productivity in various plants. - New products in advanced stages of customer approval, expected to contribute from Q3 FY27. - Polycarbonate project on track for commissioning by June 2028. - Positive tailwinds expected due to regulatory changes in China impacting nitration capacities. - Focus on stable supply supporting customers' downstream expansions. - Financial and operational metrics suggest improving margins and volumes, supporting a robust business outlook. For precise current order book or pending orders data, investor relations contact (Mr. Somsekhar Nanda or Mr. Gopal Thakkar) may be approached as suggested by management.